In order to achieve the purpose, the technical scheme of the invention is as follows: the high-stability reduced glutathione for injection is characterized in that: when the amount of the reduced glutathione is 0.6g, the formula components are as follows: reduced glutathione 0.6g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 2g When the amount of the reduced glutathione for injection is 1.0g, the formula components are as follows: reduced glutathione 1.0g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 3.3g When the reduced glutathione for injection is 1.5g, the formula components are as follows: reduced glutathione 1.5g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 5.0g Wherein, in the liquid preparation process, nitrogen is continuously filled in the liquid preparation and filling processes to keep the oxygen content in the solution below 1.5 ppm
The most successful results are seen in patients who are fully committed to a comprehensive weight management program
GLP-2 does not significantly change lymph TG concentration, TG output (mL TG per hour) or chylomicron size (TG:apoB48) compared to placebo control, rather it increases the cumulative increase in lymph TG in 60 min (Stahel et al., 2019)
Malaguarnera M
No, Ozempic is not FDA-approved for weight loss, and compounded semaglutide is not FDA-approved for any use, although it may be available during shortages of other FDA-approved semaglutide medications, or when the patient needs a custom dose or formulation that isnt commercially available
